Doctor Matthew M Y Lee

Dr Matthew Lee is a Cardiology Clinical Senior Lecturer and Honorary Consultant Cardiologist (from 2024) at the University of Glasgow. He trained in Cardiology and General Internal Medicine in Edinburgh (2005-2012) and Glasgow (2012-2023). He was awarded the Bellahouston Medal for his PhD at the University of Glasgow (2022), based on the SUGAR-DM-HF trial. He is a CardioVascular Clinical Trialists (CVCT) Future Trialists Fellow (from 2022). His interests include clinical trials, HF, cardiomyopathy, obesity/weight loss, diabetes, pharmacotherapy (SGLT2i, GLP-1RA, cardiac myosin inhibitor), systematic review, meta-analysis, and multi-modality imaging (CMR, kidney MRI, TTE, lung ultrasound). He is co-CI for BIOPEF, and PI for EVEREST, REACH-HFpEF, UK HFpEF Registry. He serves on trial steering committees (SEQUOIA-HCM) and clinical event committees (FINEARTS-HF, REVIVED-BCIS2, CABG-ACS). He serves on editorial boards (European Journal of Heart Failure, Current Heart Failure Reports).